- Generic name
- Palonosetron
- Strength
- .075 mg/1.5 ml
- Dosage form
- Injection
- Manufactured by
- Opsonin Pharma Limited
Panoset Injection
About Panoset .075 mg/1.5 ml Injection
Panoset comes as a injection with.075 mg/1.5 ml of Palonosetron, from Opsonin Pharma Limited. Only a doctor can decide if it is appropriate for a particular person and situation.
There are 16 brands of Palonosetron listed in Bangladesh.
What is Panoset .075 mg/1.5 ml Injection?
Panoset.075 mg/1.5 ml injection is a medicine made by Opsonin Pharma Limited. Panoset is an injection that contains Palonosetron, a medicine from the anti-emetic group. Panoset contains Palonosetron.075 mg/1.5 ml and belongs to a group of medicines called anti-emetics. The doctor decides whether it is suitable and how it should be taken.
Uses of Panoset
Only a doctor can decide if it is appropriate for a particular person and situation. It is an anti-emetic, a medicine that acts against vomiting. This medicine is used to control nausea and vomiting in several situations. Your doctor will decide if it is right for your situation.
How to use Panoset
Panoset is an injection, so it is given by a doctor or other trained healthcare professional. Do not inject it yourself unless a doctor has shown you how. Follow your doctor's instructions carefully. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Panoset
If you notice any side effect that worries you, or if it does not settle, tell your doctor or pharmacist. Do not try to treat side effects yourself without asking a healthcare professional first. Do not self-treat side effects without advice. Tell your doctor or nurse if you notice any side effect after the injection, or if you have any concerns about how you feel.
Safety and precautions
There is no known antidote for overdose, so treatment is supportive. Only the doctor can decide whether this injection is appropriate for you. If you are pregnant or breastfeeding, ask your doctor first; the medicine is in pregnancy category B, and it is not known if it passes into breast milk. Tell your doctor about all the other medicines you take.
Frequently asked questions
What does Panoset treat?
Only a doctor can decide if it is appropriate for a particular person and situation. It is an anti-emetic, a medicine that acts against vomiting.
How is Panoset used?
Panoset is an injection, so it is given by a doctor or other trained healthcare professional. Do not inject it yourself unless a doctor has shown you how.
What are the side effects of Panoset?
If you notice any side effect that worries you, or if it does not settle, tell your doctor or pharmacist. Do not try to treat side effects yourself without asking a healthcare professional first.
Is Panoset safe for everyone?
There is no known antidote for overdose, so treatment is supportive. Only the doctor can decide whether this injection is appropriate for you.
Also available as
Indications
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy ... Read more
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy
- Radiotherapy-induced nausea and vomiting (RINV)
- Post-operative & Post-discharge nausea and vomiting (PONV & PDNV).
Pharmacology
Pharmacokinetics: Palonosetron exhibits linear dose-proportional pharmacokinetics over the doserange 1-90 pg/kg in healthy subjects and in patients with cancer. In cancer patients receiving single intravenous doses of Palonosetron in this dose range, the mean maximum plasma concentration (Cmax) ranges from 0.89 to 336 ng/ml and the area under the plasma concentration-time curve from zero to infinity (AUCo-co) ranges from 13.8 to 957 ng.h/ml. Palonosetron has a volume of distribution of approximately 6.9-7.9 L/kg, with approximately 62% bound to plasma proteins. Approximately 50% of Palonosetron is metabolized into two inactive metabolites that exhibit <1% of the 5-HT3 receptor antagonist activity. Approximately 40% of the drug is metabolised via kidney, 50% by liver CYP2D6 (mainly), CYP3A4 and CYP1A2 isoenzymes. About 50% of the drug goes under metabolism. After a single intravenous dose, approximately 40% is excreted as unchanged drug in the urine after 144 hours. Total body clearance of Palonosetron is 160±35 ml/h/kg, and renal clearance is 66.5±18.2 ml/h/kg in healthy subjects. Palonosetron exhibits a longer half-life (40 hours) and has a greater 5-HT3 receptor binding affinity.
Dosage & Administration
Chemotherapy-induced nausea and vomiting: Adult tablet dosage: 0.5 mg administered approximately 1 hour prior to the start of chemotherapy. Adult IV dosage: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before the start of chemotherapy.
Radiotherapy-induced nausea and vomiting: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before each week of radiation fraction.
Post-operative nausea and vomiting: A single IV dose of 0.075 mg should be administered over 10 seconds immediately before induction of anesthesia.
Children dosage: (1 month to 17 years): A single IV dose at 20 mcg/kg body weight. Which maximum dose is 1.5 mg.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Overdose Effects
Storage Conditions
Alternative brands of Palonosetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.